Baylor Genetics
Ping Ji is a highly experienced research development scientist currently serving as a Senior Research Development Scientist at Baylor Genetics since December 2022. Previously, Ping Ji held positions as a Senior Scientist at Fulgent Genetics, where a multiplex test for leukemia transcript expression was developed, and as an Assistant Professor at UTMB, where a novel next-generation sequencing technology was established, leading to a filed US patent. Earlier experience includes significant contributions to oncology research as a Research Scientist/Instructor at MD Anderson Cancer Center and as a Research Scientist at the University of Münster, where pioneering work on DNA damage response models and metastasis suppressor identification was conducted. Ping Ji received a Ph.D. in Molecular Biology from the Graduate School of Chinese Academy of Agricultural Sciences and a Bachelor's Degree in Biology from Soochow University.
Baylor Genetics
Baylor Genetics is a joint venture of H.U. Group Holdings, Inc. and Baylor College of Medicine, including the #1 NIH-funded Department of Molecular and Human Genetics. Located in Houston’s Texas Medical Center, Baylor Genetics serves clients in 50 states and 16 countries.